Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology · Systolic Anterior Motion (SAM)

What is Mitral Valve SAM in Hypertrophic Cardiomyopathy?

At a Glance

Systolic anterior motion (SAM) occurs when fast-moving blood pulls the mitral valve forward as the heart beats. Common in hypertrophic cardiomyopathy, SAM can block blood from leaving the heart and cause a leaky valve, leading to symptoms like shortness of breath and dizziness.

If your echocardiogram report mentions SAM, or Systolic Anterior Motion of the mitral valve, it simply means that one of your heart’s valves is being pulled out of its normal position when your heart squeezes [1].

In Hypertrophic Cardiomyopathy (HCM), the heart muscle becomes unusually thick. This thickness changes how blood flows through your heart, which can temporarily push and drag the mitral valve forward into the path of the exiting blood [2].

The Push and Pull of Your Mitral Valve

To understand SAM, it helps to picture the anatomy of your heart. The left ventricle is the main pumping chamber. When it squeezes (a phase called systole), blood is pushed out through a pathway called the left ventricular outflow tract (LVOT).

In HCM, the thickened heart muscle—especially the wall separating the left and right sides of the heart (the septum)—narrows this exit pathway [3]. Because the pathway is narrower, blood has to rush through it much faster [4].

This fast-moving blood acts like a rapid river in a narrow canyon. As it flows past the mitral valve—a small “door” that is supposed to stay tightly closed—two things happen:

  1. The Push (Drag Force): The heavy, fast flow of blood physically pushes against the valve [4].
  2. The Pull (Vacuum Effect): The high-speed flow creates a vacuum or suction force (known medically as the Venturi effect) [2].

Together, these forces are sometimes so strong that they catch the front flap (the anterior leaflet) of the mitral valve and sweep it forward into the narrowed exit tract [1]. This forward movement during the squeeze is what doctors call Systolic Anterior Motion.

What Happens Because of SAM?

When SAM occurs, it causes two main mechanical issues in the heart:

1. Physical Blockage (Obstruction)

When the mitral valve is pulled forward into the narrowed exit pathway, it gets in the way of the blood trying to leave the heart [1]. This creates a physical bottleneck called LVOT obstruction [5].

Cardiologists measure the severity of this bottleneck using an LVOT gradient. A gradient is simply the pressure difference across the blockage, measured in millimeters of mercury (mmHg).

  • Under 30 mmHg: No significant obstruction.
  • 30 mmHg or higher: Considered an obstruction.
  • 50 mmHg or higher: Considered severe enough that your doctor will likely recommend specific treatments or procedures [6][7].

Your heart has to work much harder to push blood past this high-pressure blockage, which can lead to common HCM symptoms like shortness of breath, chest pain, or feeling lightheaded [8].

Important Safety Note: If you experience fainting (syncope) or severe dizziness, seek immediate medical attention, as this can be a warning sign that your brain temporarily isn’t getting enough oxygen.

2. A Leaky Valve (Mitral Regurgitation)

The mitral valve is supposed to close tightly to prevent blood from flowing backward into the heart’s upper chamber (the left atrium). Because SAM pulls the front flap of the valve out of place, the valve’s two flaps can no longer meet properly to form a tight seal [9].

This poor seal allows blood to leak backward, usually to the side and back (posteriorly directed). This condition is called mitral regurgitation [2]. In HCM, this leakiness is almost always a direct result of SAM [5].

Note: Sometimes, the natural shape of a person’s mitral valve—such as having slightly longer flaps or differently positioned attachment muscles—can make the valve more prone to getting caught in the fast-moving blood flow [10][11].

Triggers and Treatment: What You Can Do

While seeing “SAM” on your report can be scary, it is very common in obstructive HCM and is highly treatable.

Managing Triggers
Because the forces pulling the valve rely heavily on blood volume, being dehydrated, getting overheated, or eating heavy meals can temporarily reduce the amount of fluid in your heart and make SAM worse. Stay well-hydrated, and always consult your doctor before taking diuretics (water pills) or medications that open up blood vessels (vasodilators).

Medical and Procedural Options

  • Medications: Standard drugs like beta-blockers help the heart relax and pump less forcefully [12]. Newer, targeted medications called cardiac myosin inhibitors (like mavacamten and aficamten) specifically target the heart muscle proteins to reduce the force of the contraction, heavily reducing the vacuum effect and stopping the valve from being pulled forward [13][14].
  • Procedures: If medications aren’t enough to reduce the gradient, procedures can physically remove the bottleneck. A surgical myectomy removes a small amount of the thickened muscle, widening the pathway and eliminating the vacuum effect [15]. Another option for some patients is an alcohol septal ablation (ASA), a less invasive catheter procedure that shrinks the thickened muscle [16]. Relieving the obstruction typically fixes the leaky valve at the same time [17].

Common questions in this guide

What causes SAM of the mitral valve?
SAM is typically caused by a thickened heart muscle narrowing the heart's exit pathway. As blood rushes through this narrow space, it creates a vacuum effect that pulls the mitral valve forward into the fast-moving blood flow.
What does an LVOT gradient mean on my echocardiogram?
An LVOT gradient measures the pressure difference caused by a blockage in the heart's exit pathway. A gradient of 30 mmHg or higher indicates an obstruction, and 50 mmHg or higher is considered severe enough to typically require specific treatment.
How does SAM cause a leaky mitral valve?
When the mitral valve is pulled forward by fast-moving blood, its two flaps cannot close tightly together. This poor seal allows blood to leak backward into the upper chamber of the heart, a condition known as mitral regurgitation.
Can dehydration or heavy meals make SAM worse?
Yes. Being dehydrated, getting overheated, or eating heavy meals can temporarily reduce the amount of fluid in your heart. This lower blood volume makes the vacuum effect stronger, worsening the pull on the mitral valve.
How is systolic anterior motion treated?
SAM is treated by managing the underlying obstruction in the heart. Options include medications like beta-blockers or cardiac myosin inhibitors to relax the heart muscle, or procedures like a surgical myectomy to widen the exit pathway.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my peak LVOT gradient, both at rest and when I exercise, and does it mean I need to start or change medications?
  2. 2.Is the mitral regurgitation noted on my echo entirely caused by SAM, or is there an underlying structural problem with the valve itself?
  3. 3.Which physical activities or exercises are safe for me, and which ones might make the obstruction and SAM worse?
  4. 4.Are there any medications I am currently taking—for my heart or other conditions—that might be making the obstruction worse?
  5. 5.Am I a candidate for the newer cardiac myosin inhibitors like mavacamten or aficamten?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Surgical Management for Systolic Anterior Motion (SAM) of the Mitral Valve in Obstructive Hypertrophic Myopathy.

    Usui A, Mutsuga M

    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2022; (28(4)):239-248 doi:10.5761/atcs.ra.22-00103.

    PMID: 35851569
  2. 2

    Evolving Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy.

    Nishimura RA, Schaff HV

    Journal of the American College of Cardiology 2015; (66(15)):1697-9.

    PMID: 26449140
  3. 3

    Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

    Guigui SA, Torres C, Escolar E, Mihos CG

    Journal of thoracic disease 2022; (14(6)):2309-2325 doi:10.21037/jtd-22-182.

    PMID: 35813751
  4. 4

    Numerical simulation study on systolic anterior motion of the mitral valve in hypertrophic obstructive cardiomyopathy.

    Deng L, Huang X, Yang C, et al.

    International journal of cardiology 2018; (266()):167-173 doi:10.1016/j.ijcard.2018.01.062.

    PMID: 29887442
  5. 5

    Systolic anterior motion after mitral valve repair: where do we stand in 2015?

    Alfieri O, Lapenna E

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2015; (48(3)):344-6 doi:10.1093/ejcts/ezv230.

    PMID: 26142473
  6. 6

    Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.

    Veselka J, Faber L, Liebregts M, et al.

    Journal of the American Heart Association 2017; (6(5)) doi:10.1161/JAHA.117.005735.

    PMID: 28512112
  7. 7

    Invasive therapies for symptomatic obstructive hypertrophic cardiomyopathy.

    Mehra N, Veselka J, Smedira N, Desai MY

    Progress in cardiovascular diseases 2023; (80()):46-52 doi:10.1016/j.pcad.2023.08.003.

    PMID: 37652213
  8. 8

    Norepinephrine-associated left ventricular outflow tract obstruction and systolic anterior movement.

    Mampuya WM, Dumont J, Lamontagne F

    BMJ case reports 2019; (12(12)) doi:10.1136/bcr-2018-225879.

    PMID: 31796448
  9. 9

    Systolic anterior motion-mediated mitral regurgitation and surgical management in hypertrophic obstructive cardiomyopathy.

    Wang H, Zhu Y, Quintana E, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2024; (66(5)) doi:10.1093/ejcts/ezae376.

    PMID: 39412497
  10. 10

    Anomalous papillary muscle insertion into the mitral valve leaflet in hypertrophic obstructive cardiomyopathy: a lip nevus sign in echocardiography.

    Liu J, Tan T, Wei P, et al.

    Frontiers in cardiovascular medicine 2023; (10()):1292142 doi:10.3389/fcvm.2023.1292142.

    PMID: 38124897
  11. 11

    The Role of the Submitral Apparatus in Hypertrophic Obstructive Cardiomyopathy.

    Tao J, Duan F, Long J, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2023; (36(2)):133-145 doi:10.1016/j.echo.2022.09.018.

    PMID: 36191671
  12. 12

    Medical Management (β Blocker ± Disopyramide) of Left Ventricular Outflow Gradient Secondary to Systolic Anterior Motion of the Mitral Valve After Repair.

    Kehl DW, Rader F, Pollick C, et al.

    The American journal of cardiology 2016; (118(7)):1053-6.

    PMID: 27567136
  13. 13

    Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.

    Hegde SM, Lester SJ, Solomon SD, et al.

    Journal of the American College of Cardiology 2021; (78(25)):2518-2532 doi:10.1016/j.jacc.2021.09.1381.

    PMID: 34915982
  14. 14

    Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.

    Coats CJ, Masri A, Nassif ME, et al.

    Journal of the American Heart Association 2024; (13(15)):e035993 doi:10.1161/JAHA.124.035993.

    PMID: 39056349
  15. 15

    Mitral Regurgitation in Patients With Hypertrophic Obstructive Cardiomyopathy: Implications for Concomitant Valve Procedures.

    Hong JH, Schaff HV, Nishimura RA, et al.

    Journal of the American College of Cardiology 2016; (68(14)):1497-504.

    PMID: 27687190
  16. 16

    Haemodynamic Interplay Between Concomitant Left Ventricular Outflow Tract Obstruction and Aortic Stenosis.

    Bansal P, Lodhi H, Mathews A, et al.

    Interventional cardiology (London, England) 2021; (16()):e11 doi:10.15420/icr.2020.36.

    PMID: 34194543
  17. 17

    Concomitant Mitral Valve Surgery in a Modified Morrow Procedure in Patients with Hypertrophic Obstructive Cardiomyopathy.

    Liang C, Li M, Ma R, Jian Z

    International heart journal 2025; (66(2)):252-256 doi:10.1536/ihj.24-155.

    PMID: 40159362

This page explains systolic anterior motion (SAM) for educational purposes only. Always consult your cardiologist to properly interpret your echocardiogram results and discuss treatment options.

Get notified when new evidence is published on Hypertrophic Cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.